The contribution of apolipoprotein E genetic variation to dementia risk in British South Asians
Brain Communications · 05.05.2026 · 8 (3)
DOI: 10.1093/braincomms/fcag141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 17.04.2026. Verfasst von Benjamin M Jacobs und 15 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Institute of Population Health, Queen Mary University of London, London EC1M 6BQ, UK. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guarantors of Brain post-doctoral fellowship, NIHR Clinical Lectureship, National Institute for Health and Care Research.
Themen: Demenz
Abstract (Originalsprache)
Understanding the genetic basis of dementia in diverse populations is essential to ensure that efforts to predict, prevent and treat dementia are equitable. The strongest genetic risk factor for dementia—APOE genotype—has not been assessed in population-scale cohorts of South Asian ancestry. To test whether APOE variation is associated with all-cause dementia in British South Asians, we analysed data from 51 104 volunteers in the Genes & Health study—a cohort study of British Bangladeshi and British Pakistani individuals who have undergone genotyping and consented for lifelong (England & Wales National Health Service) linkage to healthcare records. All-cause dementia was defined using electronic healthcare records. APOE genotypes were defined using phased, imputed genotype data. Cox proportional hazards models were used to assess the relationship between APOE genotype and dementia. Population attributable fractions were calculated for each APOE genotype. Phenome-wide association tests were performed to determine the impact of APOE genotype on a range of traits and diseases. We identified 614 cases of dementia and 50 490 controls without any dementia diagnostic codes. Dementia cases (n = 614, of which 451 [73.5%] were incident) were recruited at an older age (median 71.3 versus 39.0), were more likely to be male (58.6% versus 44.5%), and were more likely to carry at least one APOE ε4 allele (26.4% versus 19.6%) than controls without dementia (n = 50 490). The APOE ε4 allele was associated with all-cause dementia in a dose-dependent fashion (APOE ε4/ε4: Hazard ratio [HR] 2.7, 95% CI 1.7–4.2, P < 0.0001; APOE ε4/ε3: HR 1.5, 95% CI 1.2–1.8, P < 0.001; Cox multivariable regression models adjusted for age at recruitment, gender, genetic principal components 1–10, and genetic ancestry; all models used APOE ε3/ε3 as reference). The overall proportion of all-cause dementia cases which could be attributed to this allele was 12.9% (95% CI −5.9%–25.5%). APOE ε4 was also associated with elevated triglycerides and low-density lipoprotein (LDL) cholesterol. APOE ε4—the major genetic risk factor for sporadic dementia in European-ancestry populations—has a similar impact on dementia risk in British South Asians. Prediction and prevention studies aiming to use APOE to identify people at high risk of dementia should be inclusive of all ancestries. Genetic analysis of dementia risk in diverse populations is essential for ensuring that the downstream benefits—for prediction, prevention and drug discovery—are shared equitably.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wolfson Institute of Population Health, Queen Mary University of London, London EC1M 6BQ, UK.
- Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London E1 1FR, UK.
- Academic Centre for Health Ageing, Barts Health NHS Trust, London E11 1NR, UK.
- Centre for Neuroscience, Surgery & Trauma, The Blizard Institute, Queen Mary University of London, London E1 2AT, UK.
- Division of Psychiatry, University College London, London W1T 7NF, UK.
- Unit for Lifelong Health & Ageing, University College London, London WC1E 6BT, UK.
ORCID-Profile: Benjamin M Jacobs, Sarah Finer, Arnab Mandal, David A van Heel
Förderung
- Guarantors of Brain post-doctoral fellowship
- NIHR Clinical Lectureship
- National Institute for Health and Care Research
- Alzheimer’s Research UK
- London Network Centre Pump Prime
- Global Parkinson’s Genetics Program
- Aligning Science Across Parkinson’s
- Michael J. Fox Foundation
Zitieren
APA
Jacobs, B. M., Chandra, A., Foote, I. F., Durrani, F., Waters, S., Liu, Y., Proitsi, P., Genes & Health Research Team, Croft, C. L., Williams, D. M., Finer, S., Rison, S., Mandal, A., Siddiqui, M., van Heel, D. A., & Marshall, C. R. (2026). The contribution of apolipoprotein E genetic variation to dementia risk in British South Asians. Brain Communications, 8(3). https://doi.org/10.1093/braincomms/fcag141
Vancouver
Jacobs BM, Chandra A, Foote IF, Durrani F, Waters S, Liu Y, et al. The contribution of apolipoprotein E genetic variation to dementia risk in British South Asians. Brain Communications. 2026;8(3). doi:10.1093/braincomms/fcag141
BibTeX
@article{Jacobs2026,
author = {Jacobs, Benjamin M and Chandra, Avinash and Foote, Isabelle Francesca and Durrani, Faiza and Waters, Sheena and Liu, Yue and Proitsi, Petroula and Genes & Health Research Team, Genes & Health Research Team and Croft, Cara L and Williams, Dylan M and Finer, Sarah and Rison, Stuart and Mandal, Arnab and Siddiqui, Moneeza and van Heel, David A and Marshall, Charles R},
title = {The contribution of apolipoprotein E genetic variation to dementia risk in British South Asians},
journal = {Brain Communications},
year = {2026},
volume = {8},
number = {3},
doi = {10.1093/braincomms/fcag141}
}
EUVIMED